Stephanie Huskins, Obstetrics & Gynecology - Obstetrics Medicare: Not Enrolled in Medicare Practice Location: 6845 Mountain View Rd, Ooltewah, TN 37363 Phone: 423-910-0896 Fax: 423-910-1183 |
Michael Stephen Pippin, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6401 Mountain View Road, Suite 101, Ooltewah, TN 37363 Phone: 423-495-5890 Fax: 423-495-5899 |
Dr. Clarissa Ann Mashchak, M.D. Obstetrics & Gynecology - Reproductive Endocrinology Medicare: Accepting Medicare Assignments Practice Location: 6401 Mountain View Rd, Suite 101, Ooltewah, TN 37363 Phone: 423-495-5890 Fax: 423-495-5899 |
Tessa B Eckhardt, NP Obstetrics & Gynecology - Obstetrics Medicare: Not Enrolled in Medicare Practice Location: 6845 Mountain View Rd, Ooltewah, TN 37363 Phone: 423-910-0896 Fax: 423-910-1183 |
Dr. Emily F Evitt, M.D Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 6401 Mountain View Rd Ste 101, Ooltewah, TN 37363 Phone: 423-495-5890 Fax: 423-495-5899 |
Matthew A Roberts, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6845 Mountain View Rd, Ooltewah, TN 37363 Phone: 423-910-0896 Fax: 423-910-1183 |
Dr. Terry Lee Williams Jr., D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6845 Mountain View Rd, Ooltewah, TN 37363 Phone: 423-910-0895 Fax: 423-910-1183 |
News Archive
Brain metastases can only develop if cancer cells first exit the fine blood vessels and enter into the brain tissue.
Apheresis, the simple process of drawing blood, becomes a powerful therapeutic in extracorporeal photopherisis (ECP) according to clinicians and scientists who met at the NIH State of the Science Symposium in Therapeutic Apheresis. Nora Ratcliffe, MD, of Dartmouth Hitchcock, looked at current methodology and opportunities for research in a paper recently published in Transfusion Medicine Review, titled "National Institutes of Health State of the Science Symposium in Therapeutic Apheresis: Scientific Opportunities in Extracorporeal Photopheresis."
A new study published on the preprint server medRxiv in July 2020 reports the potential of cell-free DNA as a marker of the severity of disease in COVID-19. This could help triage patients as well as provide a prognostic marker.
Scientists from Russia and China discovered a host of new and unexpected nanoparticles and found a way to control their composition and properties the findings that break fresh ground in the use of nanoparticles.
› Verified 2 days ago